Kendra S Carmon

14PUBLICATIONS
24CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Infant and child healthPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 23, 2026
Advances in Bispecific Antibodies and Antibody-Drug Conjugates for Colorectal Cancer Treatment.

|Jul 27, 2026
Enhancing the efficacy of B7-H3-targeting antibody-drug conjugate DS-7300a in TP53-deficient tumors by inducing ferroptosis.

|Aug 18, 2025
Anti-tumor activity of camptothecin analog conjugate of an RSPO4-based peptibody targeting LGR4/5/6 in preclinical models of colorectal cancer.

Yukimatsu Toh, Ling Wu, Jianghua Tu

|Jul 16, 2025
Cetuximab increases LGR5 expression and augments LGR5-targeting antibody-drug conjugate efficacy in patient-derived colorectal cancer models.

Peyton C High, Zhengdong Liang, Cara Guernsey-Biddle

|Dec 18, 2024
Antibody-Drug Conjugates Targeting the EGFR Ligand Epiregulin Elicit Robust Antitumor Activity in Colorectal Cancer.

Joan Jacob, Yasuaki Anami, Peyton C High

|Nov 28, 2024
Antibody-Drug Conjugates Targeting the EGFR Ligand Epiregulin Elicit Robust Anti-Tumor Activity in Colorectal Cancer.

Joan Jacob, Yasuaki Anami, Peyton High

Pageof 3

Frequent Collaborators

5 joint publications

Joan Jacob

4 joint publications

Shraddha Subramanian

4 joint publications

Peyton High

3 joint publications

Ali Azhdarinia